Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Most linked-to pages

From GxPlex

Jump to: navigation, search

Showing below up to 50 results in range #1,151 to #1,200.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 17 Paragraph 4-5 (5 links)
  2. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 18 Paragraph 1-3 (5 links)
  3. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 19 Paragraph 1 (5 links)
  4. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 19 Paragraph 2-4 (5 links)
  5. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 20 Paragraph 1-3 (5 links)
  6. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 20 Paragraph 4-7 (5 links)
  7. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 23 Paragraph 1-2 (5 links)
  8. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 23 Paragraph 3-6 (5 links)
  9. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 3-5 (5 links)
  10. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 13 (5 links)
  11. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 4 (5 links)
  12. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 31 Paragraph 2-3 (5 links)
  13. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 33 (5 links)
  14. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 34 (5 links)
  15. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 35 Paragraph 2-3 (5 links)
  16. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 50 (5 links)
  17. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 76 (5 links)
  18. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 9 (5 links)
  19. Reference:EU Regulation (EU) 536/2014 - clinical trials 27-May-2014 Preamble Preamble (5 links)
  20. Reference:FRA AEC-DM-DMDIV DOC006 v04 AAP RDM Partie II Modalités pratiques 16-May-2025 - (5 links)
  21. Reference:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 Article R1123-20-1 (5 links)
  22. Reference:FRA Code de la Santé Publique - Partie législative - 1ere partie, Livre 1er, Titre II 16-May-2025 L5311-1 (5 links)
  23. Reference:FRA DHOS/E1/DAF/DPACI no 2007-322 14-Aug-2007 2.1 (5 links)
  24. Reference:FRA DHOS/E1/DAF/DPACI no 2007-322 14-Aug-2007 2.1.2 (5 links)
  25. Reference:GBR Data Protection Act 2018 06-Jun-2022 Article 2 (5 links)
  26. Reference:GBR Data Protection Act 2018 06-Jun-2022 Schedule 10 (5 links)
  27. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (n) (5 links)
  28. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 3 (5 links)
  29. Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex X 2.2 (5 links)
  30. Reference:GBR Directive 93/42/EEC 11-Oct-2007 Article 9 (5 links)
  31. Reference:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 Appendix II (5 links)
  32. Reference:GBR MHRA GCP Inspection Dossier template V7.0 - (5 links)
  33. Reference:GBR Medicines and Medical Devices Act 2021 21-Feb-2021 Chapter 2 Article 8 (5 links)
  34. Reference:GBR NIHR - National Institute for Health and Care Research 28-Jan-2025 - (5 links)
  35. Reference:GBR The Electronic Identification and Trust Services for Electronic Transactions (Amendment etc.) (EU Exit) Regulations 2019 23-Jan-2019 - (5 links)
  36. Reference:GBR The Medical Devices Regulations 2002 11-Feb-2021 Article 2 medical device (5 links)
  37. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 14 (5 links)
  38. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (1) - (6) (5 links)
  39. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (5) (d) (5 links)
  40. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 16 (5 links)
  41. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 22-23 (5 links)
  42. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 24 (5 links)
  43. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 28 (5 links)
  44. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 investigational medicinal product (5 links)
  45. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 relevant ethics committee (5 links)
  46. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 3 (1) - (5) (5 links)
  47. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 5-6 (5 links)
  48. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 16. (5 links)
  49. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 3-001 (5 links)
  50. Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 3-002 (5 links)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://gxplex.org/index.php?title=Special:MostLinkedPages"